Ensuring Dual-Eligible Enrollees' Access to Drugs Under Part D: Mandatory Review
Dual-eligible enrollees are enrolled in both Medicaid and Medicare, and they receive prescription drug coverage under Medicare Part D. As long as Part D plans abide by certain limitations outlined in 42 CFR § 423.120, Part D sponsors have discretion to include different Part D drugs in their formularies. As required under section 3313 of the Patient Protection and Affordable Care Act, we will conduct an annual study of the extent to which formularies used by Medicare Part D plans include drugs commonly used by dual-eligible enrollees. This study will focus on Part D plans' 2025 formularies.
Announced or Revised | Agency | Title | Component | Report Number(s) | Expected Issue Date (FY) |
---|---|---|---|---|---|
February 2025 | CMS | Ensuring Dual-Eligible Enrollees' Access to Drugs Under Part D: Mandatory Review | Office of Evaluation and Inspections | OEI-05-25-00120 | 2025 |